Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Acorda's MS Drug May Not Be the Windfall Investors Expect
Acorda's MS Drug May Not Be the Windfall Investors Expect
Acorda's MS Drug May Not Be the Windfall Investors Expect
Submitted by
admin
on January 27, 2010 - 10:57am
Source:
Seeking Alpha
News Tags:
Acorda Therapeutics
MS
multiple sclerosis
Biogen Idec
AMPYRA
Headline:
Acorda's MS Drug May Not Be the Windfall Investors Expect
Do Not Allow Advertisers to Use My Personal information
